• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO MANUFACTURING USA, LLC WHITESTAR SIGNATURE; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO MANUFACTURING USA, LLC WHITESTAR SIGNATURE; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number OPO73
Medical Device Problem Code Complete Blockage (1094)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during a case doctor performed a vitrectomy and he attributed it to the post occlusion surge using opo73 tubing packs with lot number 60399685 in conjunction with the veritas sn (b)(4).No additional information was provided.This report is for the opo73.Refer to 3012236936-2023-00113 for the report of the veritas system.
 
Additional Manufacturer Narrative
Age, sex, weight, ethnicity: information was requested from the account however, it was not provided.Date of event: unknown.(b)(4).A review of records related to the device including labeling, complaint trending, and risk documentation will be performed.Upon completion of this review, if there is any further relevant information obtained, a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Additional Manufacturer Narrative
Correction: section h6 type of investigation - 4114 device not returned.In the initial report it was reported that product testing was performed however, the customer did not return the product for investigation.Manufacturing records review: the manufacturing records for the device were reviewed.The product was manufactured and released according to specification.Conclusion: as a result of the investigation there is no indication of a product quality deficiency and the reported issue could not be verified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WHITESTAR SIGNATURE
Common Device Name
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
AMO MANUFACTURING USA, LLC
510 cottonwood drive
milpitas CA 95035
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key16159864
Report Number3012236936-2023-00112
Device Sequence Number7515775
Product Code HQC
UDI-Device Identifier15050474602080
UDI-Public(01)15050474602080(17)250929(10)60399685
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K160236
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/29/2025
Device Model NumberOPO73
Device Catalogue NumberOPO73
Device Lot Number60399685
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/15/2022
Supplement Date Received by Manufacturer01/31/2023
Initial Report FDA Received Date01/13/2023
Supplement Report FDA Received Date01/31/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/29/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
VERITAS SN (B)(4).
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-